GENEVA, July 3 -- MAPP BIOPHARMACEUTICAL, INC. (4921 Directors Pl # 100San Diego, California 92121) filed a patent application (PCT/US2024/061561) for "ANTIBODIES AGAINST HENIPAVIRUSES" on Dec 20, 2024. With publication no. WO/2025/137632, the details related to the patent application was published on Jun 26, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): WEST, Brandyn (C/O Mapp Biopharmaceutical, Inc.4921 Directors Pl #100San Diego, California 92121)
Abstract:
Provided herein are Henipavirus antibodies. These Henipavirus antibodies bind to the Henipavirus F glycoprotein and have neutral...